Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.725
-0.089 (-10.97%)
Nov 21, 2024, 3:24 PM EST - Market open
Seres Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 123 | 181 | 698 | 765 | 2,236 | 242 | |
| Market Cap Growth | -52.75% | -74.06% | -8.81% | -65.78% | 825.56% | 30.80% | |
| Enterprise Value | 165 | 223 | 541 | 461 | 1,979 | 179 | |
| Last Close Price | 0.81 | 1.40 | 5.60 | 8.33 | 24.50 | 3.45 | |
| PS Ratio | 0.93 | 1.43 | 97.88 | 5.28 | 67.31 | 7.00 | |
| PB Ratio | 5.79 | -4.03 | 64.70 | 5.82 | 12.79 | -5.00 | |
| P/TBV Ratio | 6.03 | - | 64.70 | 5.82 | 12.79 | - | |
| P/OCF Ratio | - | - | - | 114.40 | - | - | |
| EV/Sales Ratio | 1.31 | 1.77 | 75.86 | 3.18 | 59.60 | 5.19 | |
| Debt / Equity Ratio | 3.91 | -4.77 | 15.08 | 0.37 | 0.23 | -0.93 | |
| Asset Turnover | 0.46 | 0.36 | 0.02 | 0.42 | 0.14 | 0.27 | |
| Quick Ratio | 1.03 | 1.38 | 2.12 | 3.53 | 5.67 | 2.10 | |
| Current Ratio | 1.12 | 1.78 | 2.28 | 3.69 | 5.79 | 2.18 | |
| Return on Equity (ROE) | -1556.28% | - | -351.62% | -42.83% | -140.99% | - | |
| Return on Assets (ROA) | -9.70% | -19.08% | -43.79% | -11.55% | -23.17% | -34.79% | |
| Return on Capital (ROIC) | -16.84% | -39.42% | -87.02% | -20.35% | -51.97% | - | |
| Earnings Yield | -18.39% | -62.84% | -35.85% | -8.57% | -3.99% | -29.10% | |
| FCF Yield | -69.26% | -34.20% | -0.38% | -4.21% | -32.10% | |
| Buyback Yield / Dilution | -14.47% | -18.44% | -17.86% | -14.93% | -40.85% | -39.04% | |
| Total Shareholder Return | -14.47% | -18.44% | -17.86% | -14.93% | -40.85% | -39.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.